Core Viewpoint - L'Oréal is advancing its beauty technology with innovative products like the AirLight Pro hair dryer and the multi-functional light energy hair straightener, showcasing a commitment to integrating advanced technology into everyday beauty tools [3][4][5]. Group 1: Product Innovations - The AirLight Pro hair dryer and the multi-functional light energy hair straightener utilize near-infrared light technology to reshape hair styling, significantly reducing damage compared to traditional high-temperature methods [5][7][9]. - The multi-functional light energy hair straightener operates at approximately 160°C, enhancing hair smoothness by two times while maintaining hair structure integrity [9]. - The LED face mask, developed in collaboration with iSmart, addresses consumer demands for portability and comfort, offering a lightweight design that enhances efficacy [11][12]. Group 2: Strategic Direction - L'Oréal's beauty technology strategy has shifted towards products that cater to mainstream consumer needs, focusing on everyday beauty tools like hair dryers and straighteners rather than niche products [15][16]. - The company emphasizes a clear strategic focus on high-certainty categories, prioritizing home-use professional devices and skin integration longevity science as key development areas [16][18]. - L'Oréal's commitment to research and innovation is evident in its development of products that not only improve performance but also redefine existing beauty categories [12][14]. Group 3: Research and Development - L'Oréal maintains a strong research foundation, ensuring that every product is backed by rigorous scientific principles, focusing on quality, safety, and performance [17][26]. - The company has developed a comprehensive beauty database that supports its research efforts, enabling rapid testing and validation of new products [26][27]. - AI plays a crucial role in L'Oréal's innovation strategy, enhancing the efficiency and depth of research while ensuring that products meet consumer needs effectively [25][29]. Group 4: Future Vision - L'Oréal envisions a future where beauty and health converge, leveraging biological mechanisms to shift consumers from passive to proactive skincare [18][19]. - The company aims to redefine beauty technology by focusing on performance, inclusivity, and precision, aligning with the evolving demands of consumers [29][30]. - Through open innovation and strategic partnerships, L'Oréal is positioned to lead in beauty technology, continuously adapting to market trends and consumer preferences [21][23].

Core Viewpoint - The article highlights the evolution of L'Oréal's research and innovation in China, emphasizing the country's transformation into a global innovation hub for the beauty industry, driven by local consumer demands and scientific advancements [4][18][41]. Group 1: Market Evolution and Innovation - The Chinese beauty market has grown to exceed 1 trillion yuan, becoming a strategic stronghold for international beauty giants and a source of global technological innovation [4][18]. - L'Oréal's China Research and Innovation Center, established in 2005, has been pivotal in driving local innovation, collaborating with top Chinese academic institutions to study health and beauty needs specific to Chinese consumers [9][10]. - The center has conducted approximately 35 large-scale foundational research projects focused on skin and hair health, developing over 300 new formulas annually tailored to Chinese consumers [15][18]. Group 2: Consumer Insights and Product Development - The demand for "science-driven efficacy" among Chinese consumers has surged, providing L'Oréal with a fertile ground for innovation [7][18]. - L'Oréal has developed unique products like Aminexil, the first imported anti-hair loss ingredient approved by China's National Medical Products Administration, showcasing the company's commitment to localized product development [17][18]. - The latest "2025 China Scalp and Hair Health White Paper" addresses key issues such as hair loss and scalp health, offering scientific solutions based on extensive consumer research [12][13]. Group 3: Collaborative Innovation Ecosystem - L'Oréal's "BIG BANG Beauty Tech Co-Creation Program" aims to integrate global startup innovations into its ecosystem, enhancing collaborative efforts across various markets [25][28]. - The company has established a collaborative innovation system across the "Beauty Golden Triangle" of China, Japan, and South Korea, leveraging each country's strengths to create a comprehensive beauty ecosystem [20][29]. - The integration of AI and biotechnology in product development is a key focus, with L'Oréal aiming to enhance its offerings through advanced scientific research [39][41]. Group 4: Future Directions and Consumer-Centric Approach - L'Oréal is shifting towards emotional experience-driven innovation, focusing on sensory science to enhance consumer engagement and satisfaction [34][41]. - The company is also exploring longevity science, aiming to provide comprehensive skin health management solutions that address aging through advanced research [36][41]. - L'Oréal emphasizes that true innovation lies in understanding and meeting consumer needs, positioning itself not just as a market leader but as a brand that prioritizes human values [41].

Core Insights - The article discusses the transformative impact of longevity science and AI on the beauty industry, emphasizing the shift in research and product development towards enhancing the quality of life rather than merely extending lifespan [5][6][10]. Group 1: Longevity Science in Beauty - Longevity science is redefining the foundational logic of beauty research, focusing on long-term skin health and preventive solutions rather than just immediate cosmetic needs [5][6]. - L'Oréal's integration of longevity science aims to transition from symptom treatment to root cause intervention, creating a comprehensive research framework that connects various aging markers to skin health [6][7]. - Companies are encouraged to develop their own longevity science theories based on their brand positioning, focusing on specific research areas like mitochondrial energy and chronic inflammation [8]. Group 2: AI's Role in Beauty Research - AI is significantly accelerating research processes in the beauty industry, with companies like L'Oréal and Unilever reporting dramatic increases in the number of molecules evaluated within shorter timeframes [11][14]. - The efficiency of AI in research is contingent upon the availability of high-quality data, necessitating the digitalization of research outcomes and the development of proprietary AI models [14]. - AI's application in ingredient discovery and development is becoming a competitive edge, with companies leveraging AI to enhance research accuracy and speed [11][14]. Group 3: PDRN and New Ingredient Trends - PDRN has emerged as a highly sought-after ingredient, with major brands like L'Oréal and Lancôme entering the market, indicating a potential surge in new product launches by 2026 [21][22]. - The development of PDRN is diversifying, with companies exploring various sources, including plant and microbial origins, to enhance efficacy and differentiate their products [22][23]. - Despite its popularity, PDRN's application in beauty products is still in its early stages, with concerns regarding its performance and safety yet to be fully validated [24]. Group 4: Advances in Peptide Technology - The beauty industry is witnessing a "technological iteration period" for recombinant collagen and functional proteins, focusing on precise structural design to address specific skin issues [25][26]. - Innovations in peptide technology include the development of multi-peptide matrices and targeted delivery systems, enhancing the effectiveness of these ingredients [26][35]. - The trend towards functionalized proteins reflects a broader industry consensus on the importance of efficacy-driven ingredient development [25][26]. Group 5: Integration of Aesthetic and Medical Approaches - The convergence of aesthetic and medical beauty is becoming a prominent trend, with brands increasingly seeking to provide scientifically validated, high-efficacy skincare solutions [30][32]. - This integration is reflected in the migration of medical-grade ingredients into consumer products, enhancing their appeal to consumers seeking immediate results [32][33]. - Brands are exploring new applications for established medical ingredients, such as PDRN and hyaluronic acid, in their product lines [32][33]. Group 6: Sensory Science and Consumer Experience - Sensory science is gaining traction in beauty research, focusing on the emotional and experiential aspects of product use, which are critical for consumer satisfaction [44][48]. - Companies are investing in technologies to quantify sensory experiences and their impact on consumer emotions, aiming to create products that resonate on a deeper level [47][48]. - The emphasis on sensory value in product development reflects a shift towards a more holistic understanding of consumer needs and preferences [44][48]. Group 7: Future Directions in Beauty Research - The article concludes that the beauty industry is entering a phase of unprecedented innovation driven by scientific advancements and consumer demand for effective, emotionally resonant products [56]. - Companies that successfully integrate rigorous scientific research with emotional engagement are likely to lead the market in the coming years [56].

Core Insights - Deep Longevity, Inc. has appointed Dylan Kay as Chief Business Officer and Luke Shaffer as Vice President of Sales for the United States, effective January 1, 2026, marking its entry into the U.S. health market [1] - The company plans to launch its commercial operations in the first quarter of 2026, focusing on four key areas: corporate health and wellness programs, health insurance and risk-bearing entities, diagnostic laboratories and longevity clinics, and high-end consumer health platforms [1] - Deep Longevity aims to sign over 50 U.S. corporate clients by the end of 2026, positioning its aging clock technology at the center of the preventive healthcare revolution [2] Company Strategy - The appointments of Kay and Shaffer are strategic moves to leverage their extensive experience in health technology and corporate partnerships to drive growth [1][2] - Deep Longevity's clinically validated aging clocks, including BloodAge, EpigeneticAge, MindAge, BiometricAge, and the upcoming FaceAge, provide actionable insights across molecular, physiological, cognitive, and psychological aging dimensions [1] - The company's SaaS solutions enable employers and insurance companies to transition from passive disease care to proactive, quantifiable personalized longevity programs that can extend healthy lifespan and reduce long-term costs [1] Market Context - The U.S. healthcare expenditure is approximately $4.5 trillion annually, with 90% attributed to chronic diseases, highlighting the significant market opportunity for Deep Longevity's solutions [2] - The leadership of Kay and Shaffer is expected to transform emerging science into enterprise-level impact, aligning with the growing focus on preventive healthcare [2]

Core Insights - Deep Longevity, Inc. has appointed Dylan Kay as Chief Business Officer and Luke Shaffer as Vice President of Sales for the U.S. market, effective January 1, 2026, indicating a strategic move to penetrate the U.S. health market [1] Group 1 - The appointment of new executives signifies Deep Longevity's commitment to expanding its presence in the largest health market globally [1] - The company plans to initiate commercial operations in the first quarter of 2026 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 （於開曼群島註冊成立之有限公司） （股份代號：���） 自願性更新營運情況 Deep Longevity於美國的業務擴展及 啟動二零二六年前委任主要高管 本公佈乃勵晶太平洋集團有限公司（「本公司」，連同其附屬公司統稱「本集團」）董事 （「董事」）會（「董事會」）按自願基準而作出，以知會本公司股東及潛在投資者下列 有關其營運的最新情況。 本 公 司 今 日 宣 佈，全 球 可 解 釋 人 工 智 能 驅 動 老 化 時 鐘 與 長 壽 科 學 的 領 導 者 Deep Longevity, Inc及其附屬公司（統稱「Deep Longevity」）委任Dylan Kay為 美利堅合眾國（「美國」）首席商務官及Luke Shaffer為美國銷售副總裁，二人均將於 二零二六年一月一日正式履新。 此次委聘標誌著Deep Longevity積極進駐全球最大的健康市場 － 美國，且已定於 二零二六年第一季度啟動商業 ...

Core Viewpoint - The stock price of Lattice Technology (00575) surged over 12% yesterday and increased by more than 35% today, currently trading at 1.05 HKD with a transaction volume of 648,600 HKD. This surge is attributed to the announcement of its subsidiary, Deep Longevity, expanding into the U.S. market in Q1 of next year, targeting the rapidly growing health market valued at over 6.8 trillion USD [1]. Company Summary - Lattice Technology's stock has shown significant growth, with a current increase of 31.25% [1]. - The company’s subsidiary, Deep Longevity, is recognized as a leader in AI-driven aging clocks and longevity science [1]. - The expansion plan into the U.S. market is set to position Deep Longevity in the largest and fastest-growing segment of the health market [1]. Industry Summary - The health market is currently valued at over 6.8 trillion USD, indicating substantial growth potential [1].

Core Viewpoint - The stock of Lijing Pacific (00575) experienced a significant increase, rising over 12% yesterday and more than 35% today, currently trading at 1.05 HKD with a transaction volume of 648,600 HKD. This surge is attributed to the announcement of its subsidiary, Deep Longevity, expanding into the U.S. market in Q1 of next year, targeting a rapidly growing health market valued at over 6.8 trillion USD [1]. Company Summary - Lijing Pacific's stock price has shown a remarkable increase, with a current rise of 31.25% [1]. - The company’s subsidiary, Deep Longevity, is recognized as a leader in AI-driven aging clocks and longevity science [1]. - The expansion plan into the U.S. market is set to position Deep Longevity within the largest and fastest-growing segment of the health market [1]. Industry Summary - The health market, which Deep Longevity aims to enter, is currently valued at over 6.8 trillion USD, indicating substantial growth potential [1].

Core Viewpoint - The stock price of Lattice Technology Pacific (00575) surged over 12% yesterday and increased by more than 35% today, currently trading at 1.05 HKD with a transaction volume of 648,600 HKD [1] Company Summary - Lattice Technology Pacific announced that its wholly-owned subsidiary, Deep Longevity, a leader in AI-driven aging clocks and longevity science, will initiate an expansion plan into the U.S. market in the first quarter of next year [1] - This expansion will position Deep Longevity in the core of the largest and fastest-growing health market globally, which is currently valued at over 6.8 trillion USD [1]

Core Viewpoint - The article highlights the innovative strategies and leadership of Barbara Lavernos at L'Oréal, emphasizing the company's commitment to research and development as a key driver for future growth in the beauty industry [2][3][4]. Group 1: Leadership and Innovation - Barbara Lavernos has been pivotal in L'Oréal's transformation, overseeing a research team of over 4,000 scientists and managing an annual R&D budget exceeding €130 million (approximately 1.1 billion RMB) [4][6]. - Under her leadership, L'Oréal has launched over 3,000 new products annually, contributing 10% to 15% of the company's revenue from new products [6][7]. - The company has maintained a strong focus on quality, safety, and performance in its products, with a significant emphasis on patent applications as a measure of innovation [7][11]. Group 2: Research and Development Focus - L'Oréal's R&D strategy includes investments in life sciences, artificial intelligence, beauty technology, and sustainability, with a notable increase in patent applications, reaching 694 in 2024 [11][12]. - The company has established a comprehensive technology matrix for its "New Age Beauty" initiative, integrating cutting-edge research into consumer products [17][20]. - L'Oréal's Chinese R&D center has been instrumental in driving innovation, with 372 patent applications filed in 2024, showcasing the center's significant contributions to the company's global innovation strategy [24][31]. Group 3: Strategic Initiatives - The BIG BANG initiative launched in China aims to foster open innovation by collaborating with promising startups in AI, biotechnology, and pharmaceutical technology [29][30]. - L'Oréal's commitment to long-term research in longevity science positions it as a leader in the beauty industry's future, focusing on the aging process and its implications for skincare [14][15]. - The integration of AI into L'Oréal's R&D processes has significantly accelerated product development, allowing for the evaluation of 150 molecules in a fraction of the time previously required [21][22].